More than 40 million people around the world suffer from Alzheimer's disease, and that number is expected to increase dramatically in the coming years. What is Alzheimer's disease? Alzheimer's disease is a progressive brain disorder that causes a progressive and irreversible loss of higher brain functions such as memory, language skills, and perception of time and space.
A synthetic form of insulin improves symptoms of cognitive decline associated with Alzheimer's disease. American researchers have developed an effective treatment for people diagnosed with mild cognitive impairment and Alzheimer's-related dementia. It is a synthetic form of insulin, which is administered through a nasal spray, and which improves working memory and other cognitive abilities in people suffering from this type of dementia.